An investigational anti-B7-H3 antibody-drug conjugate proposed for the treatment of adult patients with extensive-stage small cell lung cancer with disease progression on or after platinum-based chemotherapy.
An investigational anti-B7-H3 antibody-drug conjugate proposed for the treatment of adult patients with extensive-stage small cell lung cancer with disease progression on or after platinum-based chemotherapy.